Tyagi Shaifali, Sharma Neera, Tyagi Jaya Sivaswami, Haldar Sagarika
Center for Bio-design & Diagnostics, Translational Health Science & Technology Institute, NCR Biotech Science Cluster, 3rd Milestone, Faridabad - Gurgaon Expressway, PO Box No 04, Faridabad 121001, India.
Department of Biochemistry, Dr RML Hospital, New Delhi 110001, India.
Future Microbiol. 2017 Oct;12:1201-1218. doi: 10.2217/fmb-2017-0028. Epub 2017 Sep 15.
Pleural tuberculosis (pTB) is a grave form of extrapulmonary tuberculosis. Microbiological tests are usually found to be inadequate for pTB diagnosis. The absence of a uniform 'composite reference standard' is challenging; therefore, diagnosis is usually performed using a combination of diversified criteria. Nucleic acid tests vary in diagnostic accuracy and have not yet been integrated into clinical decision making. This review assesses the varied criteria used for pTB classification and the challenges afflicting pleural fluid-based DNA diagnostic tests, namely, PCR and Xpert MTB/RIF. In the 58 studies (PCR: n = 33; Xpert: n = 25) analyzed, reference standards were heterogeneous and PCR/Xpert pooled sensitivity values (range: 0-100%) were inadequate. However, the consistent high specificity of Xpert (range: 90-100%) indicated its utility as a 'rule-in' test. There is an urgent need to evaluate existing and new molecular tests in well-designed studies to accurately assess their utility for pTB diagnosis. To conclude, rapid and accurate tests are warranted for pTB diagnosis.
胸膜结核(pTB)是肺外结核的一种严重形式。微生物学检测通常被发现不足以用于pTB诊断。缺乏统一的“综合参考标准”具有挑战性;因此,诊断通常采用多种标准相结合的方式进行。核酸检测的诊断准确性各不相同,尚未纳入临床决策。本综述评估了用于pTB分类的各种标准以及基于胸腔积液的DNA诊断检测(即PCR和Xpert MTB/RIF)所面临的挑战。在分析的58项研究中(PCR:n = 33;Xpert:n = 25),参考标准各不相同,PCR/Xpert的合并敏感性值(范围:0 - 100%)并不理想。然而,Xpert始终具有较高的特异性(范围:90 - 100%),表明其作为一种“确诊”检测的效用。迫切需要在设计良好的研究中评估现有的和新的分子检测,以准确评估它们对pTB诊断的效用。总之,pTB诊断需要快速且准确的检测。